APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharma Ophthalmic

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pharma Ophthalmic Industry Growth and Trends Forecast to 2032

26 December 2025103 pages

Choose your research edition.

Industry ResearchPharma Ophthalmic Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharma Ophthalmic Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pharma Ophthalmic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharma Ophthalmic Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharma Ophthalmic Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Pharma Ophthalmic market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pharma Ophthalmic is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pharma Ophthalmic is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharma Ophthalmic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharma Ophthalmic include Akorn, Allergan, Regeneron, Senju, Valeant, Bayer, Santen, Pfizer and Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pharma Ophthalmic market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pharma Ophthalmic market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharma Ophthalmic market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharma Ophthalmic.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pharma Ophthalmic market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pharma Ophthalmic Market by Company

Akorn

Allergan

Regeneron

Senju

Valeant

Bayer

Santen

Pfizer

Roche

Novartis

Pharma Ophthalmic Segment by Type

Retinal disorders drugs

Glaucoma drugs

Other ophthalmic drugs

Allergic, inflammatory and infective drugs

Dry eye drugs

Pharma Ophthalmic Segment by Application

Dry eye syndrome

Other ophthalmic indications

Glaucoma

Retinal diseases

Pharma Ophthalmic Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Ophthalmic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharma Ophthalmic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Ophthalmic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pharma Ophthalmic manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pharma Ophthalmic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Retinal disorders drugs Table 2. Major Company of Glaucoma drugs Table 3. Major Company of Other ophthalmic drugs Table 4. Major Company of Allergic, inflammatory and infective drugs Table 5. Major Company of Dry eye drugs Table 6. Global Pharma Ophthalmic Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Pharma Ophthalmic Sales by Type (2021-2026) & (W Units) Table 8. Global Pharma Ophthalmic Sales Market Share in Volume by Type (2021-2026) Table 9. Global Pharma Ophthalmic Sales by Type (2021-2026) & (US$ Million) Table 10. Global Pharma Ophthalmic Sales Market Share in Value by Type (2021-2026) Table 11. Global Pharma Ophthalmic Price by Type (2021-2026) & (US$/Unit) Table 12. Global Pharma Ophthalmic Sales by Type (2027-2032) & (W Units) Table 13. Global Pharma Ophthalmic Sales Market Share in Volume by Type (2027-2032) Table 14. Global Pharma Ophthalmic Sales by Type (2027-2032) & (US$ Million) Table 15. Global Pharma Ophthalmic Sales Market Share in Value by Type (2027-2032) Table 16. Global Pharma Ophthalmic Price by Type (2027-2032) & (US$/Unit) Table 17. North America Pharma Ophthalmic Sales by Type (2021-2026) & (W Units) Table 18. North America Pharma Ophthalmic Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Pharma Ophthalmic Sales by Type (2021-2026) & (W Units) Table 20. Europe Pharma Ophthalmic Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Pharma Ophthalmic Sales by Type (2021-2026) & (W Units) Table 22. Asia-Pacific Pharma Ophthalmic Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Pharma Ophthalmic Sales by Type (2021-2026) & (W Units) Table 24. Latin America Pharma Ophthalmic Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Pharma Ophthalmic Sales by Type (2021-2026) & (W Units) Table 26. Middle East and Africa Pharma Ophthalmic Sales by Type (2021-2026) & (US$ Million) Table 27. Pharma Ophthalmic Industry Trends Table 28. Pharma Ophthalmic Industry Drivers Table 29. Pharma Ophthalmic Industry Opportunities and Challenges Table 30. Pharma Ophthalmic Industry Restraints Table 31. Global Pharma Ophthalmic Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Pharma Ophthalmic Revenue Market Share by Company (2021-2026) Table 33. Global Pharma Ophthalmic Sales by Company (2021-2026) & (W Units) Table 34. Global Pharma Ophthalmic Sales Share by Company (2021-2026) Table 35. Global Pharma Ophthalmic Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Pharma Ophthalmic Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Pharma Ophthalmic Major Company Production Sites and Headquarters Table 38. Global Pharma Ophthalmic Company, Product Type & Application Table 39. Global Pharma Ophthalmic Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Pharma Ophthalmic by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Pharma Ophthalmic Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Pharma Ophthalmic Sales by Region (2021-2026) & (W Units) Table 44. Global Pharma Ophthalmic Sales Market Share in Volume by Region (2021-2026) Table 45. Global Pharma Ophthalmic Sales by Region (2021-2026) & (US$ Million) Table 46. Global Pharma Ophthalmic Sales Market Share in Value by Region (2021-2026) Table 47. Global Pharma Ophthalmic Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Pharma Ophthalmic Sales by Region (2027-2032) & (W Units) Table 49. Global Pharma Ophthalmic Sales Market Share in Volume by Region (2027-2032) Table 50. Global Pharma Ophthalmic Sales by Region (2027-2032) & (US$ Million) Table 51. Global Pharma Ophthalmic Sales Market Share in Value by Region (2027-2032) Table 52. Global Pharma Ophthalmic Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Pharma Ophthalmic Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Pharma Ophthalmic Sales by Application (2021-2026) & (W Units) Table 55. Global Pharma Ophthalmic Sales Market Share in Volume by Application (2021-2026) Table 56. Global Pharma Ophthalmic Sales by Application (2021-2026) & (US$ Million) Table 57. Global Pharma Ophthalmic Sales Market Share in Value by Application (2021-2026) Table 58. Global Pharma Ophthalmic Price by Application (2021-2026) & (US$/Unit) Table 59. Global Pharma Ophthalmic Sales by Application (2027-2032) & (W Units) Table 60. Global Pharma Ophthalmic Sales Market Share in Volume by Application (2027-2032) Table 61. Global Pharma Ophthalmic Sales by Application (2027-2032) & (US$ Million) Table 62. Global Pharma Ophthalmic Sales Market Share in Value by Application (2027-2032) Table 63. Global Pharma Ophthalmic Price by Application (2027-2032) & (US$/Unit) Table 64. North America Pharma Ophthalmic Sales by Application (2021-2026) & (W Units) Table 65. North America Pharma Ophthalmic Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Pharma Ophthalmic Sales by Application (2021-2026) & (W Units) Table 67. Europe Pharma Ophthalmic Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Pharma Ophthalmic Sales by Application (2021-2026) & (W Units) Table 69. Asia-Pacific Pharma Ophthalmic Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Pharma Ophthalmic Sales by Application (2021-2026) & (W Units) Table 71. Latin America Pharma Ophthalmic Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Pharma Ophthalmic Sales by Application (2021-2026) & (W Units) Table 73. Middle East and Africa Pharma Ophthalmic Sales by Application (2021-2026) & (US$ Million) Table 74. Akorn Company Information Table 75. Akorn Business Overview Table 76. Akorn Pharma Ophthalmic Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Akorn Pharma Ophthalmic Product Portfolio Table 78. Akorn Recent Development Table 79. Allergan Company Information Table 80. Allergan Business Overview Table 81. Allergan Pharma Ophthalmic Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Allergan Pharma Ophthalmic Product Portfolio Table 83. Allergan Recent Development Table 84. Regeneron Company Information Table 85. Regeneron Business Overview Table 86. Regeneron Pharma Ophthalmic Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Regeneron Pharma Ophthalmic Product Portfolio Table 88. Regeneron Recent Development Table 89. Senju Company Information Table 90. Senju Business Overview Table 91. Senju Pharma Ophthalmic Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Senju Pharma Ophthalmic Product Portfolio Table 93. Senju Recent Development Table 94. Valeant Company Information Table 95. Valeant Business Overview Table 96. Valeant Pharma Ophthalmic Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Valeant Pharma Ophthalmic Product Portfolio Table 98. Valeant Recent Development Table 99. Bayer Company Information Table 100. Bayer Business Overview Table 101. Bayer Pharma Ophthalmic Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Bayer Pharma Ophthalmic Product Portfolio Table 103. Bayer Recent Development Table 104. Santen Company Information Table 105. Santen Business Overview Table 106. Santen Pharma Ophthalmic Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Santen Pharma Ophthalmic Product Portfolio Table 108. Santen Recent Development Table 109. Pfizer Company Information Table 110. Pfizer Business Overview Table 111. Pfizer Pharma Ophthalmic Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Pfizer Pharma Ophthalmic Product Portfolio Table 113. Pfizer Recent Development Table 114. Roche Company Information Table 115. Roche Business Overview Table 116. Roche Pharma Ophthalmic Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Roche Pharma Ophthalmic Product Portfolio Table 118. Roche Recent Development Table 119. Novartis Company Information Table 120. Novartis Business Overview Table 121. Novartis Pharma Ophthalmic Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Novartis Pharma Ophthalmic Product Portfolio Table 123. Novartis Recent Development Table 124. North America Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 125. North America Pharma Ophthalmic Sales by Country (2021-2026) & (W Units) Table 126. North America Pharma Ophthalmic Sales Market Share by Country (2021-2026) Table 127. North America Pharma Ophthalmic Sales Forecast by Country (2027-2032) & (W Units) Table 128. North America Pharma Ophthalmic Sales Market Share Forecast by Country (2027-2032) Table 129. North America Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. North America Pharma Ophthalmic Market Size by Country (2021-2026) & (US$ Million) Table 131. North America Pharma Ophthalmic Market Share by Country (2021-2026) Table 132. North America Pharma Ophthalmic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. North America Pharma Ophthalmic Market Share Forecast by Country (2027-2032) Table 134. Europe Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 135. Europe Pharma Ophthalmic Sales by Country (2021-2026) & (W Units) Table 136. Europe Pharma Ophthalmic Sales Market Share by Country (2021-2026) Table 137. Europe Pharma Ophthalmic Sales Forecast by Country (2027-2032) & (W Units) Table 138. Europe Pharma Ophthalmic Sales Market Share Forecast by Country (2027-2032) Table 139. Europe Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Europe Pharma Ophthalmic Market Size by Country (2021-2026) & (US$ Million) Table 141. Europe Pharma Ophthalmic Market Share by Country (2021-2026) Table 142. Europe Pharma Ophthalmic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Europe Pharma Ophthalmic Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Pharma Ophthalmic Sales by Country (2021-2026) & (W Units) Table 146. Asia-Pacific Pharma Ophthalmic Sales Market Share by Country (2021-2026) Table 147. Asia-Pacific Pharma Ophthalmic Sales Forecast by Country (2027-2032) & (W Units) Table 148. Asia-Pacific Pharma Ophthalmic Sales Market Share Forecast by Country (2027-2032) Table 149. Asia-Pacific Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Asia-Pacific Pharma Ophthalmic Market Size by Country (2021-2026) & (US$ Million) Table 151. Asia-Pacific Pharma Ophthalmic Market Share by Country (2021-2026) Table 152. Asia-Pacific Pharma Ophthalmic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Asia-Pacific Pharma Ophthalmic Market Share Forecast by Country (2027-2032) Table 154. Latin America Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 155. Latin America Pharma Ophthalmic Sales by Country (2021-2026) & (W Units) Table 156. Latin America Pharma Ophthalmic Sales Market Share by Country (2021-2026) Table 157. Latin America Pharma Ophthalmic Sales Forecast by Country (2027-2032) & (W Units) Table 158. Latin America Pharma Ophthalmic Sales Market Share Forecast by Country (2027-2032) Table 159. Latin America Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Latin America Pharma Ophthalmic Market Size by Country (2021-2026) & (US$ Million) Table 161. Latin America Pharma Ophthalmic Market Share by Country (2021-2026) Table 162. Latin America Pharma Ophthalmic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Latin America Pharma Ophthalmic Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Pharma Ophthalmic Sales by Country (2021-2026) & (W Units) Table 166. Middle East and Africa Pharma Ophthalmic Sales Market Share by Country (2021-2026) Table 167. Middle East and Africa Pharma Ophthalmic Sales Forecast by Country (2027-2032) & (W Units) Table 168. Middle East and Africa Pharma Ophthalmic Sales Market Share Forecast by Country (2027-2032) Table 169. Middle East and Africa Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Middle East and Africa Pharma Ophthalmic Market Size by Country (2021-2026) & (US$ Million) Table 171. Middle East and Africa Pharma Ophthalmic Market Share by Country (2021-2026) Table 172. Middle East and Africa Pharma Ophthalmic Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Middle East and Africa Pharma Ophthalmic Market Share Forecast by Country (2027-2032) Table 174. Key Raw Materials Table 175. Raw Materials Key Suppliers Table 176. Pharma Ophthalmic Distributors List Table 177. Pharma Ophthalmic Customers List Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources Table 181. Primary Sources List of Figures Figure 1. Pharma Ophthalmic Image Figure 2. Global Pharma Ophthalmic Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharma Ophthalmic Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharma Ophthalmic Sales (2021-2032) & (W Units) Figure 5. Retinal disorders drugs Image Figure 6. Global Retinal disorders drugs Sales YoY Growth (2021-2032) & (W Units) Figure 7. Glaucoma drugs Image Figure 8. Global Glaucoma drugs Sales YoY Growth (2021-2032) & (W Units) Figure 9. Other ophthalmic drugs Image Figure 10. Global Other ophthalmic drugs Sales YoY Growth (2021-2032) & (W Units) Figure 11. Allergic, inflammatory and infective drugs Image Figure 12. Global Allergic, inflammatory and infective drugs Sales YoY Growth (2021-2032) & (W Units) Figure 13. Dry eye drugs Image Figure 14. Global Dry eye drugs Sales YoY Growth (2021-2032) & (W Units) Figure 15. Global Pharma Ophthalmic Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Pharma Ophthalmic Market Share by Type 2025 VS 2032 Figure 17. North America Pharma Ophthalmic Sales Market Share in Volume by Type in 2025 Figure 18. North America Pharma Ophthalmic Sales Market Share in Value by Type in 2025 Figure 19. Europe Pharma Ophthalmic Sales Market Share in Volume by Type in 2025 Figure 20. Europe Pharma Ophthalmic Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Pharma Ophthalmic Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Pharma Ophthalmic Sales Market Share in Value by Type in 2025 Figure 23. Latin America Pharma Ophthalmic Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Pharma Ophthalmic Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Pharma Ophthalmic Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Pharma Ophthalmic Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Pharma Ophthalmic Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Dry eye syndrome Image Figure 30. Global Dry eye syndrome Sales YoY Growth (2021-2032) & (W Units) Figure 31. Other ophthalmic indications Image Figure 32. Global Other ophthalmic indications Sales YoY Growth (2021-2032) & (W Units) Figure 33. Glaucoma Image Figure 34. Global Glaucoma Sales YoY Growth (2021-2032) & (W Units) Figure 35. Retinal diseases Image Figure 36. Global Retinal diseases Sales YoY Growth (2021-2032) & (W Units) Figure 37. Global Pharma Ophthalmic Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Pharma Ophthalmic Market Share by Application 2025 VS 2032 Figure 39. North America Pharma Ophthalmic Sales Market Share in Volume by Application in 2025 Figure 40. North America Pharma Ophthalmic Sales Market Share in Value by Application in 2025 Figure 41. Europe Pharma Ophthalmic Sales Market Share in Volume by Application in 2025 Figure 42. Europe Pharma Ophthalmic Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Pharma Ophthalmic Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Pharma Ophthalmic Sales Market Share in Value by Application in 2025 Figure 45. Latin America Pharma Ophthalmic Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Pharma Ophthalmic Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Pharma Ophthalmic Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Pharma Ophthalmic Sales Market Share in Value by Application in 2025 Figure 49. North America Pharma Ophthalmic Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. North America Pharma Ophthalmic Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Pharma Ophthalmic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Pharma Ophthalmic Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Pharma Ophthalmic Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Europe Pharma Ophthalmic Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Pharma Ophthalmic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Pharma Ophthalmic Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Pharma Ophthalmic Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Asia-Pacific Pharma Ophthalmic Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Pharma Ophthalmic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Pharma Ophthalmic Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Pharma Ophthalmic Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 62. Latin America Pharma Ophthalmic Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Pharma Ophthalmic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Pharma Ophthalmic Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Pharma Ophthalmic Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 66. Middle East and Africa Pharma Ophthalmic Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Pharma Ophthalmic Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Pharma Ophthalmic Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Pharma Ophthalmic Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Pharma Ophthalmic Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Retinal disorders drugs
  • Glaucoma drugs
  • Other ophthalmic drugs
  • Allergic, inflammatory and infective drugs
  • Dry eye drugs
Applications
  • Dry eye syndrome
  • Other ophthalmic indications
  • Glaucoma
  • Retinal diseases
Companies covered
  • Akorn
  • Allergan
  • Regeneron
  • Senju
  • Valeant
  • Bayer
  • Santen
  • Pfizer
  • Roche
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharma Ophthalmic Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pharma Ophthalmic Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pharma Ophthalmic Market by Type
  6. 1.3.1 Retinal disorders drugs
  7. 1.3.2 Glaucoma drugs
  8. 1.3.3 Other ophthalmic drugs
  9. 1.3.4 Allergic, inflammatory and infective drugs
  10. 1.3.5 Dry eye drugs
  11. 1.4 Global Pharma Ophthalmic Market Size by Type
  12. 1.4.1 Global Pharma Ophthalmic Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Pharma Ophthalmic Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Pharma Ophthalmic Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Pharma Ophthalmic Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Pharma Ophthalmic Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Pharma Ophthalmic Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Pharma Ophthalmic Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Pharma Ophthalmic Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pharma Ophthalmic Industry Trends
  2. 2.2 Pharma Ophthalmic Industry Drivers
  3. 2.3 Pharma Ophthalmic Industry Opportunities and Challenges
  4. 2.4 Pharma Ophthalmic Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pharma Ophthalmic Revenue (2021-2026)
  2. 3.2 Global Top Players by Pharma Ophthalmic Sales (2021-2026)
  3. 3.3 Global Top Players by Pharma Ophthalmic Price (2021-2026)
  4. 3.4 Global Pharma Ophthalmic Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pharma Ophthalmic Major Company Production Sites & Headquarters
  6. 3.6 Global Pharma Ophthalmic Company, Product Type & Application
  7. 3.7 Global Pharma Ophthalmic Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pharma Ophthalmic Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pharma Ophthalmic Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pharma Ophthalmic Tier 1, Tier 2, and Tier 3
4 Pharma Ophthalmic Regional Status and Outlook
  1. 4.1 Global Pharma Ophthalmic Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pharma Ophthalmic Historic Market Size by Region
  3. 4.2.1 Global Pharma Ophthalmic Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pharma Ophthalmic Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pharma Ophthalmic Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pharma Ophthalmic Forecasted Market Size by Region
  7. 4.3.1 Global Pharma Ophthalmic Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pharma Ophthalmic Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pharma Ophthalmic Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pharma Ophthalmic by Application
  1. 5.1 Pharma Ophthalmic Market by Application
  2. 5.1.1 Dry eye syndrome
  3. 5.1.2 Other ophthalmic indications
  4. 5.1.3 Glaucoma
  5. 5.1.4 Retinal diseases
  6. 5.2 Global Pharma Ophthalmic Market Size by Application
  7. 5.2.1 Global Pharma Ophthalmic Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Pharma Ophthalmic Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Pharma Ophthalmic Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Pharma Ophthalmic Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Pharma Ophthalmic Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Pharma Ophthalmic Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Pharma Ophthalmic Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Pharma Ophthalmic Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Akorn
  2. 6.1.1 Akorn Company Information
  3. 6.1.2 Akorn Business Overview
  4. 6.1.3 Akorn Pharma Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Akorn Pharma Ophthalmic Product Portfolio
  6. 6.1.5 Akorn Recent Developments
  7. 6.2 Allergan
  8. 6.2.1 Allergan Company Information
  9. 6.2.2 Allergan Business Overview
  10. 6.2.3 Allergan Pharma Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Allergan Pharma Ophthalmic Product Portfolio
  12. 6.2.5 Allergan Recent Developments
  13. 6.3 Regeneron
  14. 6.3.1 Regeneron Company Information
  15. 6.3.2 Regeneron Business Overview
  16. 6.3.3 Regeneron Pharma Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Regeneron Pharma Ophthalmic Product Portfolio
  18. 6.3.5 Regeneron Recent Developments
  19. 6.4 Senju
  20. 6.4.1 Senju Company Information
  21. 6.4.2 Senju Business Overview
  22. 6.4.3 Senju Pharma Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Senju Pharma Ophthalmic Product Portfolio
  24. 6.4.5 Senju Recent Developments
  25. 6.5 Valeant
  26. 6.5.1 Valeant Company Information
  27. 6.5.2 Valeant Business Overview
  28. 6.5.3 Valeant Pharma Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Valeant Pharma Ophthalmic Product Portfolio
  30. 6.5.5 Valeant Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer Pharma Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bayer Pharma Ophthalmic Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 Santen
  38. 6.7.1 Santen Company Information
  39. 6.7.2 Santen Business Overview
  40. 6.7.3 Santen Pharma Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Santen Pharma Ophthalmic Product Portfolio
  42. 6.7.5 Santen Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Pharma Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Pharma Ophthalmic Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 Roche
  50. 6.9.1 Roche Company Information
  51. 6.9.2 Roche Business Overview
  52. 6.9.3 Roche Pharma Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Roche Pharma Ophthalmic Product Portfolio
  54. 6.9.5 Roche Recent Developments
  55. 6.10 Novartis
  56. 6.10.1 Novartis Company Information
  57. 6.10.2 Novartis Business Overview
  58. 6.10.3 Novartis Pharma Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novartis Pharma Ophthalmic Product Portfolio
  60. 6.10.5 Novartis Recent Developments
7 North America by Country
  1. 7.1 North America Pharma Ophthalmic Sales by Country
  2. 7.1.1 North America Pharma Ophthalmic Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pharma Ophthalmic Sales by Country (2021-2026)
  4. 7.1.3 North America Pharma Ophthalmic Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pharma Ophthalmic Market Size by Country
  6. 7.2.1 North America Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pharma Ophthalmic Market Size by Country (2021-2026)
  8. 7.2.3 North America Pharma Ophthalmic Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pharma Ophthalmic Sales by Country
  2. 8.1.1 Europe Pharma Ophthalmic Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pharma Ophthalmic Sales by Country (2021-2026)
  4. 8.1.3 Europe Pharma Ophthalmic Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pharma Ophthalmic Market Size by Country
  6. 8.2.1 Europe Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pharma Ophthalmic Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pharma Ophthalmic Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pharma Ophthalmic Sales by Country
  2. 9.1.1 Asia-Pacific Pharma Ophthalmic Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pharma Ophthalmic Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pharma Ophthalmic Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pharma Ophthalmic Market Size by Country
  6. 9.2.1 Asia-Pacific Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pharma Ophthalmic Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pharma Ophthalmic Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pharma Ophthalmic Sales by Country
  2. 10.1.1 South America Pharma Ophthalmic Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pharma Ophthalmic Sales by Country (2021-2026)
  4. 10.1.3 South America Pharma Ophthalmic Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pharma Ophthalmic Market Size by Country
  6. 10.2.1 South America Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pharma Ophthalmic Market Size by Country (2021-2026)
  8. 10.2.3 South America Pharma Ophthalmic Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pharma Ophthalmic Sales by Country
  2. 11.1.1 Middle East and Africa Pharma Ophthalmic Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pharma Ophthalmic Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pharma Ophthalmic Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pharma Ophthalmic Market Size by Country
  6. 11.2.1 Middle East and Africa Pharma Ophthalmic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pharma Ophthalmic Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pharma Ophthalmic Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pharma Ophthalmic Value Chain Analysis
  2. 12.1.1 Pharma Ophthalmic Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pharma Ophthalmic Production Mode & Process
  7. 12.2 Pharma Ophthalmic Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pharma Ophthalmic Distributors
  10. 12.2.3 Pharma Ophthalmic Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst